High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure

Journal of the American College of Cardiology

Volumn 36, Issue 5, 2000, Pages 1587-1593

  Maeda, Keiko ^a   Tsutamoto, Takayoshi ^a   Wada, Atsuyuki ^a   Mabuchi, Naoko ^a   Hayashi, Masaru ^a   Tsutsui, Takashi ^a   Ohnishi, Masato ^a   Sawaki, Masahide ^a   Fujii, Masanori ^a   Matsumoto, Takehiro ^a   Kinoshita, Masahiko ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; FEMALE; FOLLOW UP; HEART DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PATIENT MONITORING; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

AGED; BIOLOGICAL FACTORS; CHRONIC DISEASE; CYTOKINES; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; NERVE TISSUE PROTEINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME;

EID: 0034332845     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)00912-8     Document Type: Article

References (33)

1. The neurohumoral axis in congestive heart failure
2. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure
3. Neurohormonal interactions and adaptations in congestive heart failure
4. Neuroendocrine activity in untreated heart failure
5. Increased plasma endothelin-1 in pulmonary hypertension: Marker or mediator of disease?
6. Plasma endothelin correlates with extent of pulmonary hypertension in patients with chronic heart failure
7. Relation between endothelin-1 spillover in the lungs and pulmonary vascular resistance in patients with chronic heart failure
8. Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure
9. Hormones regulating cardiovascular function in patients with severe congestive heart failure and relation to mortality
10. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure
11. N-terminal proatrial natriuretic factor: An independent predictor of long-term prognosis after myocardial infarction
12. Effect of long-term enalapril therapy on neurohormones in patients with left ventricular dysfunction
13. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction
14. Plasma brain peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction: Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide
15. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction: Comparison with plasma angiotensin II and endothelin-1
16. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure
17. Basic mechanism in congestive heart failure: Recognizing the role of proinflammatory cytokines
18. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure
19. Negative inotropic effects of cytokines on the heart mediated by nitric oxide
20. Increased levels of serum neopterin and decreased production of neutrophil superoxide anions in chronic heart failure with elevated levels of tumor necrosis factor-alpha
21. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the Studies Of Left Ventricular Dysfunction (SOLVD)
22. Interleukin-6 spillover in the peripheral circulation increase with the severity of heart failure and the high plasma levels of interleukin-6 is an important prognostic predictor in patients with congestive heart failure
23. Role of cytokines in the mechanism of action of amlodipine: The PRAISE heart failure trial
24. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction
25. Sequential neurohumoral measurements in patients with congestive heart failure
26. Left ventricular volume from paired biplane ventriculography
27. Reversible restrictive left ventricular diastolic filling with optimized oral therapy predicts a more favorable prognosis in patients with chronic heart failure
28. Prognostic usefulness of repeated echocardiographic evaluation after acute myocardial infarction
29. Plasma brain natriuretic peptide as an indicator for angiotensin-converting enzyme inhibition after myocardial infarction
30. Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction
31. Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarction
32. Hypoxic stress induces cardiac myocyte-derived interleukin-6
33. Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure